abstract |
The present invention relates to inhibitors of potassium channel function (especially inhibitors of the K v 1 subfamily of voltage-gated K + channels, in particular K v 1.5 linked to the K + current I Kur of the ultra-rapidly activated delayed rectifier. The present invention relates to a novel cycloalkyl compound useful as an inhibitor, a method of using the compound for the prevention and treatment of arrhythmia and I Kur -related pathologies, and a pharmaceutical composition containing the compound. |